A drug commonly used to treat epilepsy could be repurposed to significantly boost the response to vaccines in humans, helping protect those for whom the vaccine is less effective, such as the elderly or immunocompromised.
Repurposed epilepsy drug could be used to boost vaccine protection among elderly
20 October 2026
1 min read